Our Companies

Medgenome is being India’s leading genomic diagnostics and research company which leverages South Asia’s unique founder populations to discover better diagnostics, screening tests and novel drug targets that address significant unmet needs across global markets.

Awarded MedTech Breakthrough award for biomedical research in 2018.

Theragen is developing medicine to treat diabetic retinopathy, the leading cause of vision loss for diabetics worldwide at 1/9th the current cost.

OncoPept is developing new therapies that empower the human immune system to beat cancer.

Ready to start two clinical trials. 

Malignant Pleural Mesothelioma and HPV.

Head and Neck squamous cell carcinoma.

AgriGenome is being India’s leading plant and animal genomics company with 800+ research clients and a world-class seed development program.

Rice seed varieties that provide 25% more yield and 15-day decreased production cycle, is entering the regulatory approval process in 2019.

MagGenome is making biomedical research more effective and cost efficient through its patented magnetic nano-particle technology.

Antlera is creating solutions for bone and tissue regeneration, addressing long unsolved issues including bone growth, hair loss and GI repair.

Saksin is developing a better and more affordable biologic drug to cure adult blindness caused by wet AMD at 1/9th the current cost.

ModMab is leveraging the protein engineering revolution to develop new cancer medicines.

Modular Medically relevant antibody (ModMab) Therapeutics is a mid-stage drug development company with significant antibody drug candidate portfolio.

Emerge Biologics is believing that bio-betters can fill massive unmet patient and health system needs by accelerating the timelines for novel therapies, that act on known targets, to become available in emerging markets.